Skip to main content
. 2026 Mar 17;18(3):372. doi: 10.3390/pharmaceutics18030372
OS Osteosarcoma
CDDP Cisplatin
ROS Reactive oxygen species
DNA Deoxyribonucleic acid
DMEM Dulbecco’s modified Eagle’s medium
FBS Fetal bovine serum
FITC Fluorescein isothiocyanate
PI Propidium iodide
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazoliumbromide
DMSO Dimethyl sulfoxide
PBS Phosphate-buffered saline
PE Plating efficiency
SF Surviving fraction
DHR-123 Dihydrorhodamine-123
MCS Multicellular spheroids
FDA Fluorescein diacetate
s.c. Injected subcutaneously
i.p. Intraperitoneal
TGR Tumor growth rates
H&E Hematoxylin and eosin
HPF High-power field
NA Necrotic area
VA Viable area
TNR Tumor necrotic rate
ATNR Adjusted tumor necrotic rate
RTGR Relative tumor growth rates
GOT Aspartate aminotransferase
ALT Alanine aminotransferase
SEM Standard error of the mean
SI Selectivity index
o-HVA 2-hydroxy-3-methoxybenzaldehyde
MCR Multicellular resistance
ECM Extracellular matrix